Vascular reconstruction: A major challenge in developing a functional whole solid organ graft from decellularized organs
Source abstract
Abstract
Bioengineering a functional organ holds great potential to overcome the current gap between the organ need and shortage of available organs. Whole organ decellularization allows the removal of cells from large-scale organs, leaving behind extracellular matrices containing different growth factors, structural proteins, and a vascular network with a bare surface. Successful application of decellularized tissues as transplantable organs is hampered by the inability to completely reline the vasculature by endothelial cells (ECs), leading to blood coagulation, loss of vascular patency, and subsequent death of reseeded cells. Therefore, an intact, continuous layer of endothelium is essential to maintain proper functioning of the vascular system, which includes the transfer of nutrients to surrounding tissues and protecting other types of cells from shear stress. Here, we aimed to summarize the available cell sources that can be used for reendothelialization in addition to different trials performed by researchers to reconstruct vascularization of decellularized solid organs. Additionally, different techniques for enhancing reendothelialization and the methods used for evaluating reendothelialization efficiency along with the future prospective applications of this field are discussed. STATEMENT OF SIGNIFICANCE: Despite the great progress in whole organ decellularization, reconstruction of vasculature within the engineered constructs is still a major roadblock. Reconstructed endothelium acts as a multifunctional barrier of vessels, which can reduce thrombosis and help delivering of oxygen and nutrients throughout the whole organ. Successful reendothelialization can be achieved through reseeding of appropriate cell types on the naked vasculature with or without modification of its surface. Here, we present the current research milestones that so far established to reconstruct the vascular network in addition to the methods used for evaluating the efficiency of reendotheilization. Thus, this review is quite significant and will aid the researchers to know where we stand toward biofabricating a transplantable organ from decellularizd extracellular matrix.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications · Infectious Aortic and Vascular Conditions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. http://www.transplant-observatory.org/[accessed: July2018].
2. Will regenerative medicine replace transplantation?10.1101/cshperspect.a015693 ↗
3. Biocompatibility evaluation of tissue-engineered decellularized scaffolds for biomedical application10.1016/j.msec.2016.05.068 ↗
4. Tissue engineering10.1126/science.8493529 ↗
5. An overview of tissue and whole organ decellularization processes10.1016/j.biomaterials.2011.01.057 ↗
6. Solid organ fabrication: comparison of decellularization to 3D bioprinting10.1186/s40824-016-0074-2 ↗
7. Tissue engineering by decellularization and 3D bioprinting10.1016/j.mattod.2016.12.005 ↗
8. Heparin-gelatin mixture improves vascular reconstruction efficiency and hepatic function in bioengineered livers10.1016/j.actbio.2016.04.042 ↗
9. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart10.1038/nm1684 ↗
10. Tissue specificity of decellularized rhesus monkey kidney and lung scaffolds10.1371/journal.pone.0064134 ↗
11. Regeneration and orthotopic transplantation of a bioartificial lung10.1038/nm.2193 ↗
12. Tissue-engineered lungs for in vivo implantation10.1126/science.1189345 ↗
13. Bioengineered transplantable porcine livers with re-endothelialized vasculature10.1016/j.biomaterials.2014.11.027 ↗
14. Human-scale liver harvest and decellularization for preclinical research10.1007/7651_2018_195 ↗
15. Biocompatibility and hemocompatibility of efficiently decellularized whole porcine kidney for tissue engineering10.1002/jbm.a.36407 ↗
16. A nonhuman primate model of lung regeneration: detergent-mediated decellularization and initial in vitro recellularization with mesenchymal stem cells10.1089/ten.tea.2011.0594 ↗
17. Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation10.1038/srep13079 ↗
18. Decellularized rhesus monkey kidney as a three-dimensional scaffold for renal tissue engineering10.1089/ten.tea.2009.0602 ↗
19. Vasculature reconstruction of decellularized liver scaffolds via gelatin-based re-endothelialization10.1002/jbm.a.36551 ↗
20. Acellular human heart matrix: a critical step toward whole heart grafts10.1016/j.biomaterials.2015.04.056 ↗
21. Bioartificial heart: a human-sized porcine model–the way ahead10.1371/journal.pone.0111591 ↗
22. Sustained perfusion of revascularized bioengineered livers heterotopically transplanted into immunosuppressed pigs
23. Fabrication of a biodegradable xenoantigen-free rat liver scaffold for potential drug screening applications10.1016/j.transproceed.2013.08.016 ↗
24. Recellularization via the bile duct supports functional allogenic and xenogenic cell growth on a decellularized rat liver scaffold10.1080/15476278.2016.1276146 ↗
25. Mesenchymal stem cells support hepatocyte function in engineered liver grafts10.4161/org.27879 ↗
26. Production and implantation of renal extracellular matrix scaffolds from porcine kidneys as a platform for renal bioengineering investigations10.1097/SLA.0b013e31825a02ab ↗
27. Improving functional re-endothelialization of acellular liver scaffold using REDV cell-binding domain10.1016/j.actbio.2018.07.046 ↗
28. Cell sheet-based tissue engineering for fabricating 3-dimensional heart tissues10.1253/circj.CJ-14-0973 ↗
29. 3D biofabrication of vascular networks for tissue regeneration: a report on recent advances10.1016/j.jpha.2018.08.005 ↗
30. In vitro model of a vascular stroma for the engineering of vascularized tissues10.1054/ijom.2001.0130 ↗
31. The use of whole organ decellularization for the generation of a vascularized liver organoid10.1002/hep.24067 ↗
32. In vivo performance of decellularized vascular grafts: a review article10.3390/ijms19072101 ↗
33. Base structure consisting of an endothelialized vascular-tree network and hepatocytes for whole liver engineering10.1016/j.jbiosc.2013.05.020 ↗
34. Engineering the vasculature of decellularized rat kidney scaffolds using human induced pluripotent stem cell-derived endothelial cells10.1038/s41598-019-44393-y ↗
35. Recellularization of well-preserved acellular kidney scaffold using embryonic stem cells10.1089/ten.tea.2013.0269 ↗
36. Regenerative potential of human airway stem cells in lung epithelial engineering10.1016/j.biomaterials.2016.08.055 ↗
37. Perfusion decellularization of human and porcine lungs: bringing the matrix to clinical scale10.1016/j.healun.2013.10.030 ↗
38. Giving new life to old lungs: methods to produce and assess whole human paediatric bioengineered lungs10.1002/term.2113 ↗
39. Transplantation of bioengineered rat lungs recellularized with endothelial and adipose-derived stromal cells10.1038/s41598-017-09115-2 ↗
40. Three-dimensional scaffolds of acellular human and porcine lungs for high throughput studies of lung disease and regeneration10.1016/j.biomaterials.2013.11.078 ↗
41. Excitation propagation in three-dimensional engineered hearts using decellularized extracellular matrix10.1016/j.biomaterials.2014.05.080 ↗
42. Whole organ tissue vascularization: engineering the tree to develop the fruits10.3389/fbioe.2018.00056 ↗
43. Regeneration and experimental orthotopic transplantation of a bioengineered kidney10.1038/nm.3154 ↗
44. Targeted proteomics effectively quantifies differences between native lung and detergent-decellularized lung extracellular matrices10.1016/j.actbio.2016.09.043 ↗
45. Optimizing recellularization of whole decellularized heart extracellular matrix10.1371/journal.pone.0090406 ↗
46. Bioengineering human lung grafts on porcine matrix10.1097/SLA.0000000000002129 ↗
47. Enhanced re-endothelialization of decellularized rat lungs10.1089/ten.tec.2016.0012 ↗
48. Enhanced re-endothelialization of acellular kidney scaffolds for whole organ engineering via antibody conjugation of vasculatures
49. Vascularization of engineered tissues: approaches to promote angio-genesis in biomaterials10.2174/156802608783790983 ↗
50. Origins of circulating endothelial cells and endothelial outgrowth from blood10.1172/JCI8071 ↗
51. Endothelial cells in physiology and in the pathophysiology of vascular disorders
52. Endothelial signaling during development10.1038/nm0603-661 ↗
53. Vascular tissue engineering: progress, challenges, and clinical promise10.1016/j.stem.2018.02.009 ↗
54. Endothelial cell harvest for seeding vascular prostheses: the influence of technique on cell function, viability, and number10.1016/0741-5214(86)90195-3 ↗
55. Small-diameter vascular tissue engineering10.1038/nrcardio.2013.77 ↗
56. Generation, expansion and functional analysis of endothelial cells and pericytes derived from human pluripotent stem cells10.1038/nprot.2014.102 ↗
57. Tissue engineering: creation of long-lasting blood vessels10.1038/428138a ↗
58. Surface modification and endothelialization of polyurethane for vascular tissue engineering applications: a review10.1039/C6BM00618C ↗
59. Towards organ printing: engineering an intra-organ branched vascular tree10.1517/14712590903563352 ↗
60. Decellularized tissue-engineered blood vessel as an arterial conduit10.1073/pnas.1019506108 ↗
61. Endothelialization of heart valve matrix using a computer-assisted pulsatile bioreactor10.1089/ten.tea.2008.0250 ↗
62. Decellularization and recellularization of rat livers with hepatocytes and endothelial progenitor cells10.1111/aor.12645 ↗
63. Are endothelial progenitor cells the real solution for cardiovascular diseases? focus on controversies and perspectives10.1155/2015/835934 ↗
64. Nephrosphere-derived cells are induced to multilineage differentiation when cultured on human decellularized kidney scaffolds10.1016/j.ajpath.2017.09.012 ↗
65. Vascular smooth muscle enhances functionality of tissue-engineered blood vessels in vivo10.1016/j.jvs.2010.07.054 ↗
66. A highly efficient method to differentiate smooth muscle cells from human embryonic stem cells10.1161/ATVBAHA.107.154260 ↗
67. Regulation of vascular smooth muscle cell bioenergetic function by protein glutathiolation10.1016/j.bbabio.2009.11.005 ↗
68. The development of a tissue-engineered artery using decellularized scaffold and autologous ovine mesenchymal stem cells10.1016/j.biomaterials.2009.09.049 ↗
69. Regenerative capacity of adipose derived stem cells (ADSCs), comparison with mesenchymal stem cells (MSCs)10.3390/ijms20102523 ↗
70. Adipose tissue-derived stem cells as a therapeutic tool for cardiovascular disease10.4330/wjc.v7.i8.454 ↗
71. Differentiation of adult stem cells into smooth muscle for vascular tissue engineering10.1016/j.jss.2009.08.001 ↗
72. Lancet commission: stem cells and regenerative medicine10.1016/S0140-6736(17)31366-1 ↗
73. Functional kidney bioengineering with pluripotent stem-cell-derived renal progenitor cells and decellularized kidney scaffolds10.1002/adhm.201600120 ↗
74. Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells10.1038/ncomms3307 ↗
75. Engineering pulmonary vasculature in decellularized rat and human lungs10.1038/nbt.3354 ↗
76. Human pluripotent stem cell culture: current status, challenges, and advancement10.1155/2018/7396905 ↗
77. The RNA exosome nuclease complex regulates human embryonic stem cell differentiation10.1083/jcb.201811148 ↗
78. The potential and challenges of using stem cells for cardiovascular repair and regeneration10.1016/j.gendis.2014.07.003 ↗
79. Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation10.1089/ten.tea.2009.0730 ↗
80. Natural scaffolds for renal differentiation of human embryonic stem cells for kidney tissue engineering10.1371/journal.pone.0143849 ↗
81. Decellularization of whole human liver grafts using controlled perfusion for transplantable organ bioscaffolds10.1089/scd.2017.0095 ↗
82. Co-immobilization of CD133 antibodies, vascular endothelial growth factors, and REDV peptide promotes capture, proliferation, and differentiation of endothelial progenitor cells10.1016/j.actbio.2019.07.004 ↗
83. Hemocompatibility improvement of perfusion-decellularized clinical-scale liver scaffold through heparin immobilization10.1038/srep10756 ↗
84. Heparin-eluting electrospun nanofiber yarns for antithrombotic vascular sutures10.1021/acsami.7b14888 ↗
85. Gelatin based microfluidic devices for cell culture10.1039/b517524k ↗
86. Vascular endothelial cell adhesion and spreading promoted by the peptide REDV of the IIICS region of plasma fibronectin is mediated by integrin alpha 4 beta 110.1016/S0021-9258(19)49672-5 ↗
87. Construction of sinusoid-scale microvessels in perfusion culture of a decellularized liver
88. Endothelial barrier function under laminar fluid shear stress10.1038/labinvest.3780193 ↗
89. Identification of an alternatively spliced site in human plasma fibronectin that mediates cell type-specific adhesion10.1083/jcb.103.6.2637 ↗
90. Recent advances to accelerate re-endothelialization for vascular stents10.1177/2041731417731546 ↗
91. Low molecular weight fucoidan prevents neointimal hyperplasia in rabbit iliac artery in-stent restenosis model10.1161/01.ATV.0000032034.91020.0A ↗
92. Smooth muscle cells: a novel site of P-selectin expression with pathophysiological and therapeutic relevance in pulmonary hypertension10.1164/rccm.201812-2242ED ↗
93. Chondroitin sulfate coatings display low platelet but high endothelial cell adhesive properties favorable for vascular implants10.1021/bm5003762 ↗
94. Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells10.1074/jbc.M003084200 ↗
95. Laminin deposition in the extracellular matrix: a complex picture emerges10.1242/jcs.041095 ↗
96. Remodelling the extracellular matrix in development and disease10.1038/nrm3904 ↗
97. Identification of endothelial cell binding sites on the laminin gamma 1 chain10.1161/01.RES.84.6.688 ↗
98. The effect of heparin-VEGF multilayer on the biocompatibility of decellularized aortic valve with platelet and endothelial progenitor cells10.1371/journal.pone.0054622 ↗
99. Controlled growth factor delivery for tissue engineering10.1002/adma.200900241 ↗
100. Covalent growth factor immobilization strategies for tissue repair and regeneration10.1002/mabi.201000505 ↗